Growth hormone deficiency MRI

Growth hormone deficiency Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Growth hormone deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Growth hormone deficiency MRI On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Growth hormone deficiency MRI All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Growth hormone deficiency MRI
CDC on Growth hormone deficiency MRI
Growth hormone deficiency MRI in the news
Blogs on Growth hormone deficiency MRI
Directions to Hospitals Treating Growth hormone deficiency
Risk calculators and risk factors for Growth hormone deficiency MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: {MAD}}

Overview

• There are no MRI findings associated with [disease name].

OR

• [Location] MRI may be helpful in the diagnosis of [disease name]. Findings on MRI suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

• There are no MRI findings associated with [disease name]. However, an MRI may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

MRI

• [Location] MRI may be helpful in the diagnosis of [disease name]. Findings on MRI suggestive of/diagnostic of [disease name] include:
• MRI is highly sensitive to visualize the hypothalamo-hypophyseal tract. After the clinical and biochemical diagnosis of GHD is made [32].

• On T1-weighted imaging, a clear demarcation can be made between the adenohypophysis (after two months of age) and the neurohypophysis, which appears as hyperintense [73]

• This imaging is important to exclude the possibility of a pituitary tumor; it also permits diagnostic characterization by showing the presence or absence of morphological abnormalities such as anterior pituitary hypoplasia, pituitary stalk agenesis, and posterior pituitary ectopia.

• MRI may also provide evidence of severe GHD

• The diagnosis of pituitary stalk interruption syndrome (PSIS) is made [74].

Case courtesy of A.Prof Frank Gaillard, Radiopaedia.org, rID: 16814